Ucsf Kidney Transplant Fac is categorized under in San Francisco, CA and active since 1996.
Ucsf Kidney Transplant Fac was established in 1996, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sue Vega, Office Manager at the company’s single location by writing to 505 Parnassus Avenue, San Francisco, California CA 94143 or by phoning (415) 353-1640. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ucsf Kidney Transplant Fac |
| Contact Person: | Sue Vega, Office Manager |
| Address: | 505 Parnassus Avenue, San Francisco, California 94143 |
| Phone Number: | (415) 353-1640 |
| Website Address: | radiology.ucsf.edu |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 8069 |
| NAICS Code: | 6211110 |
| Share This Business: |
Ucsf Kidney Transplant Fac was started in 1996 to provide professional under the SIC code 8069 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Sue Vega, Office Manager for inquiries that concern Ucsf Kidney Transplant Fac by calling the company number (415) 353-1640, as your correspondence is most welcome. Additionally, the physical location of the single location of Ucsf Kidney Transplant Fac can be found at the coordinates 37.76324,-122.45866 as well as the street address 505 Parnassus Avenue in San Francisco, California 94143.
For its online presence, you may visit Ucsf Kidney Transplant Fac’s website at radiology.ucsf.edu and engage with its social media outlets through on Twitter and on Facebook.